BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11408727)

  • 1. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease.
    Dupuy AM; Mas E; Ritchie K; Descomps B; Badiou S; Cristol JP; Touchon J
    Gerontology; 2001; 47(4):213-8. PubMed ID: 11408727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.
    Mulder M; Ravid R; Swaab DF; de Kloet ER; Haasdijk ED; Julk J; van der Boom JJ; Havekes LM
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):198-203. PubMed ID: 9772023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between gene polymorphism at the apolipoprotein E locus and serum lipid profile in urban children of school age in Beijing].
    Zhu W; Feng N; Wang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):297-300. PubMed ID: 11769625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
    Poirier J; Delisle MC; Quirion R; Aubert I; Farlow M; Lahiri D; Hui S; Bertrand P; Nalbantoglu J; Gilfix BM; Gauthier S
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12260-4. PubMed ID: 8618881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum apolipoprotein A I, B100 and E levels and apolipoprotein E polymorphism in patients with Alzheimer's disease and multiple infarction dementia in Chinese population].
    Fan P; Liu Y; Zhang Z; Liu B; Ge W; Ye S; Cheng Y; Chen J
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):389-91. PubMed ID: 12536572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism and serum lipids in a randomized, prospective trial of an infant diet with reduced saturated fat and cholesterol.
    Lapinleimu H; Viikari J; Rönnemaa T; Välimäki I; Tuominen J; Marniemi J; Ehnholm C; Jokinen E; Simell O
    Pediatrics; 1996 Oct; 98(4 Pt 1):757-62. PubMed ID: 8885957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan.
    Nakayama S; Kuzuhara S
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.
    González C; Martín T; Cacho J; Breñas MT; Arroyo T; García-Berrocal B; Navajo JA; González-Buitrago JM
    Eur J Clin Invest; 1999 Jul; 29(7):637-42. PubMed ID: 10411671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.
    Wingo TS; Cutler DJ; Wingo AP; Le NA; Rabinovici GD; Miller BL; Lah JJ; Levey AI
    JAMA Neurol; 2019 Jul; 76(7):809-817. PubMed ID: 31135820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the effect of the apolipoprotein E genotype on the lipid profile in Alzheimer's disease.
    Sabbagh MN; Sandhu S; Kolody H; Lahti T; Silverberg NB; Sparks DL
    Curr Alzheimer Res; 2006 Apr; 3(2):157-60. PubMed ID: 16611016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
    Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
    Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease.
    Isbir T; Agaçhan B; Yilmaz H; Aydin M; Kara I; Eker E; Eker D
    Am J Alzheimers Dis Other Demen; 2001; 16(2):77-81. PubMed ID: 11302074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.
    Emanuele E; Peros E; Tomaino C; Feudatari E; Bernardi L; Binetti G; Maletta R; D'Angelo A; Montagna L; Bruni AC; Geroldi D
    Neurosci Lett; 2004 Feb; 357(1):45-8. PubMed ID: 15036610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
    Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
    Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
    Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
    Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.
    Notkola IL; Sulkava R; Pekkanen J; Erkinjuntti T; Ehnholm C; Kivinen P; Tuomilehto J; Nissinen A
    Neuroepidemiology; 1998; 17(1):14-20. PubMed ID: 9549720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.
    Spell C; Kölsch H; Lütjohann D; Kerksiek A; Hentschel F; Damian M; von Bergmann K; Rao ML; Maier W; Heun R
    Dement Geriatr Cogn Disord; 2004; 18(3-4):245-9. PubMed ID: 15286454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.
    Sweet RA; Kamboh MI; Wisniewski SR; Lopez OL; Klunk WE; Kaufer DI; DeKosky ST
    J Geriatr Psychiatry Neurol; 2002; 15(1):24-30. PubMed ID: 11936240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.